Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Mandana Kamgar MD

Mandana Kamgar MD profile photo picture

Assistant Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology

image of /images/ORCIDiD_icon16x16.png

Member of the Cancer Center

Research Experience

  • Clinical Trial
  • Gastrointestinal Neoplasms
  • Pancreatic Neoplasms
  • Population Health
  • Clinical Expertise

  • Gastrointestinal Neoplasms
  • Pancreatic Neoplasms
  • Publications (42)

  • Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and Opportunities. (Chakrabarti S, Kamgar M, Mahipal A) Cancers (Basel) 2022 May 24;14(11) PMID: 35681565 06/11/2022    
  • Comparison of fluoropyrimidine based (FP)and taxane based platinum doublets (TP) in frontline treatment of patients with metastatic gastroesophageal adenocarcinomas (mGEAC): A retrospective analysis. (H Ismail, A Mohamed, Y Song, N Abdallah, M Surapaneni, S Kim, M Kamgar, J Mettu, A Akhras, A Ahmed, PA Philip, AF Shields, AA Tesfaye) J Clin Oncol 35, 2017 (suppl; abstr e15604), AACO Annual Meeting, Online Publication; Chicago, June 2017 10/11/2021    
  • Peripheral neuropathy after breast cancer: An analysis of data from the Women’s Health Initiative Life and Longevity After Cancer cohort. (M Kamgar, H Assad, TA Hastert, E McLaughlin, K Reding, ED Paskett, JW Bea, AH Shadyab, ML Neuhouser, R Nassir, TE Crane, K Sreeram, MK Greenwald, MS Simon) J Clin Oncol 38: 2020 (suppl; abstr e24093), 2020 ASCO Scientific Program, Online Publication, Virtual, May 2020 10/11/2021    
  • Impact of tumor histology and socioeconomic factors on survival of patients suffering from malignant vascular tumors of liver and hepatocellular carcinomas: A SEER database analysis. (AV Shreenivas, GSG Murthy, B George, JP Thomas, S Chakrabarti, M Kamgar, PS Ritch) J Clin Oncol 38: 2020 (suppl; abstr e16612), 2020 ASCO Scientific Program, Online Publication; Virtual, May 2020 10/11/2021    
  • Comprehensive genomic profiling in metastatic pancreatic adenocarcinoma, correlation with early death versus prolonged survival. (M Kamgar, G Dyson, AF Shields, AA Tesfaye, PA Philip, MN Al-Hallak) J Clin Oncol 37, 2019 (suppl 4; abstr 282), ASCO Gastrointestinal Cancer symposium, Poster Presentation; Saf Francisco, January 2019 10/11/2021    
  • Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology. (Hall WA, Kamgar M, Erickson BA, Ponce SB, Tsai S, Nevalainen MT, Christians KK, George B, Dua KS, Khan AH, Evans DB, Azmi AS) Cancer Metastasis Rev 2021 09;40(3):879-889 PMID: 34611794 PMCID: PMC8767496 SCOPUS ID: 2-s2.0-85116412346 10/07/2021    
  • Evolution of Systemic Therapy in Metastatic Pancreatic Ductal Adenocarcinoma (Kamgar M, Chakrabarti S, Shreenivas A, George B) Surgical Oncology Clinics of North America October 2021;30(4):673-691 SCOPUS ID: 2-s2.0-85111041414 10/01/2021    
  • Targeting cellular metabolism with CPI-613 sensitizes pancreatic cancer cells to radiotherapy (WA Hall, HY Khan, M Kamgar, S Tsai, K Christians, DB Evans, P Philip, C Clarke, B George, B Erickson, AS Azmi.) AACR Pancreatic Virtual Meeting; Poster Presentation 09/29/2021    
  • Phase II clinical trial of subtype directed neoadjuvant therapy in patients with localized pancreatic cancer. (S Tsai, E Borazanci, M Gulley, N Rashid, J Merker, AH Khan, P Chisholm, B Hunt, T Giorgadze, W Hall, M Kamgar, DB Evans, JJ Yeh) AACR Pancreatic Virtual Meeting; Poster Presentation 09/29/2021    
  • Evolution of Systemic Therapy in Metastatic Pancreatic Ductal Adenocarcinoma. (Kamgar M, Chakrabarti S, Shreenivas A, George B) Surg Oncol Clin N Am 2021 10;30(4):673-691 PMID: 34511189 SCOPUS ID: 2-s2.0-85111041414 09/14/2021    
  • Prevalence and predictors of peripheral neuropathy after breast cancer treatment. (Kamgar M, Greenwald MK, Assad H, Hastert TA, McLaughlin EM, Reding KW, Paskett ED, Bea JW, Shadyab AH, Neuhouser ML, Nassir R, Crane TE, Sreeram K, Simon MS) Cancer Med 2021 10;10(19):6666-6676 PMID: 34390205 PMCID: PMC8495292 SCOPUS ID: 2-s2.0-85112347474 08/15/2021    
  • MAGNITUDE OF CA19-9 DECLINE IN RESPONSE TO NEOADJUVANT CHEMORADIATION IS ASSOCIATED WITH OVERALL SURVIVAL IN PATIENTS WITH PANCREATIC CANCER (Sam Thalji, William Hall, Mohammed Aldakkak, Kathleen Christians, Callisia N Clarke, Ben George, Mandana Kamgar, Bryan Hunt, Srivats Madhavan, Naveen Kulkarni, Beth A Erickson, Douglas B Evans, Susan Tsai. ) Gastroenterology 160 (6), S-902 05/23/2021    
  • Impact of KRAS alterations in pancreatic ductal adenocarcinoma (PDAC). (M Mehdi, M Kamgar, B George, A Szabo, K Annunzio, BW Taylor, AV Shreenivas, S Chakrabarti, JP Thomas, S Tsai, KK Christians, DB Evans, C Clarke, WA Hall, B Erickson, G Ahmed, B Thapa) Journal of Clinical Oncology 39 (15_suppl), 4136-4136 05/20/2021    
  • Clinical outcomes in pancreatic ductal adenocarcinoma (PDAC) patients with underlying autoimmune disease (AID). (G Ahmed, K Annunzio, A Szabo, D Eastwood, B Thapa, BW Taylor, S Tsai, KK Christians, C Clarke, DB Evans, WAdrian Hall, B Erickson, M Kamgar, B George) Journal of Clinical Oncology 39 (15_suppl), e16233-e16233 05/20/2021    
  • Prevalence and predictors of peripheral neuropathy after chemotherapy: Outcomes from the Detroit Research on Cancer Survivorship (ROCS) cohort. (K Sreeram, R Seaton, M Kamgar, H Assad, MK Greenwald, JJ Ruterbusch, JL Beebe-Dimmer, AG Schwartz, MS Simon) Journal of Clinical Oncology 39 (15_suppl), 12069-12069 05/20/2021    
  • Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancer (AN Krepline, JL Geurts, B George, M Kamgar, S Madhavan, BA Erickson, WA Hall, MO Griffin, DB Evans, S Tsai, RY Kim) Surgery 169 (3), 629-635 03/01/2021    
  • CA19-9 Response to 1st-Line Neoadjuvant FOLFIRINOX and 2nd-Line Gemcitabine-Based Chemotherapy in Patients with Operable Pancreatic Cancer (S Thalji, M Kamgar, B George, M Aldakkak, K Christians, CN Clarke, B Erickson, W Hall, P Tolat, A Khan, DB Evans, S Tsai) ANNALS OF SURGICAL ONCOLOGY 28 (SUPPL 1), S20-S20 02/01/2021    
  • Impact of KRAS alterations in localized pancreatic cancer (PC). (AV Shreenivas, K Annunzio, M Kamgar, S Chakrabarti, JP Thomas, S Madhavan, K Dua, AH Khan, WA Hall, B Erickson, KK Christians, C Clarke, DB Evans, S Tsai, A Szabo, R Urrutia, MT Zimmermann, HV Reddi, B George) Journal of Clinical Oncology 39 (3_suppl), 431-431 01/20/2021    
  • Association of total neoadjuvant therapy with favorable clinical outcomes in patients with locally advanced esophageal and gastroesophageal junction adenocarcinomas (LA-GEJ CA). (L Jurkowski, AV Shreenivas, S Chakrabarti, M Kamgar, JP Thomas,L Puckett, MShukla, E Gore, J Evans, CA Johnstone, M Gasparri, P Linsky, D Johnstone, K Dua, AH Khan, S Madhavan, A Szabo, B George) ournal of Clinical Oncology 39 (3_suppl), 231-231 01/20/2021    
  • Total Neoadjuvant Therapy for Operable Pancreatic Cancer. (Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar M, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S) Ann Surg Oncol 2021 Apr;28(4):2246-2256 PMID: 33000372 SCOPUS ID: 2-s2.0-85091728559 10/02/2020       13 Citations
  • Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancer. (Krepline AN, Geurts JL, George B, Kamgar M, Madhavan S, Erickson BA, Hall WA, Griffin MO, Evans DB, Tsai S, Kim RY) Surgery 2021 03;169(3):629-635 PMID: 32826069 SCOPUS ID: 2-s2.0-85089521842 08/23/2020    
  • Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm. (Chakrabarti S, Kamgar M, Mahipal A) Cancers (Basel) 2020 Jul 24;12(8) PMID: 32722188 PMCID: PMC7465131 SCOPUS ID: 2-s2.0-85088526610 07/30/2020       30 Citations
  • Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer. (Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S) Surgery 2020 09;168(3):440-447 PMID: 32641278 SCOPUS ID: 2-s2.0-85087345792 07/10/2020       7 Citations
  • Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth. (Khan HY, Mpilla GB, Sexton R, Viswanadha S, Penmetsa KV, Aboukameel A, Diab M, Kamgar M, Al-Hallak MN, Szlaczky M, Tesfaye A, Kim S, Philip PA, Mohammad RM, Azmi AS) Cancers (Basel) 2020 Mar 22;12(3) PMID: 32235707 PMCID: PMC7140111 SCOPUS ID: 2-s2.0-85082515935 04/03/2020       15 Citations
  • Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma. (Azmi AS, Khan HY, Muqbil I, Aboukameel A, Neggers JE, Daelemans D, Mahipal A, Dyson G, Kamgar M, Al-Hallak MN, Tesfaye A, Kim S, Shidham V, M Mohammad R, Philip PA) Clin Cancer Res 2020 03 15;26(6):1338-1348 PMID: 31831564 PMCID: PMC7073299 SCOPUS ID: 2-s2.0-85081944777 12/14/2019       18 Citations
  • PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors. (Mpilla G, Aboukameel A, Muqbil I, Kim S, Beydoun R, Philip PA, Mohammad RM, Kamgar M, Shidham V, Senapedis W, Baloglu E, Li J, Dyson G, Xue Y, El-Rayes B, Azmi AS) Cancers (Basel) 2019 Nov 29;11(12) PMID: 31795447 PMCID: PMC6966587 SCOPUS ID: 2-s2.0-85075928077 12/05/2019       10 Citations
  • Goals of Treatment Sequencing for Localized Pancreatic Cancer. (Evans DB, Kamgar M, Tsai S) Ann Surg Oncol 2019 Nov;26(12):3815-3819 PMID: 31493126 SCOPUS ID: 2-s2.0-85073126378 09/08/2019       2 Citations
  • How I Treat Resectable Pancreatic Cancer With Adjuvant Therapy (PA Philip, M Kamgar) Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and Multidisciplinary Patient Care PA Philip, M Kamgar (2019).'How I Treat Resectable Pancreatic Cancer With Adjuvant Therapy', in T Bekaii-Saab, B El-Rayes, T Pawlik (ed.) Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and Multidisciplinary Patient Care: Springer Publishing Company, PP. 183-190 08/13/2019    
  • Protocols in genetic mice models of pancreatic cancer (Al-Qambar B, Chaker M, Kamgar M, Tesfaye A, Uwe-Wagner K, Azmi AS) Animal Models in Cancer Drug Discovery 17 April 2019:107-123 SCOPUS ID: 2-s2.0-85080860972 04/17/2019    
  • Comprehensive molecular profiling of patients with pancreatic adenocarcinoma: A single institution’s experience. (Kamgar M, Dyson G, Diab M, Tesfaye AA, Korn WM, Shields AF, Philip AP) Journal of Clinical Oncology 36, no. 15_suppl.e16236 06/01/2018    
  • The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities. (Tesfaye AA, Kamgar M, Azmi A, Philip PA) Expert Rev Anticancer Ther 2018 02;18(2):131-148 PMID: 29254387 PMCID: PMC6121777 SCOPUS ID: 2-s2.0-85043376842 12/20/2017       22 Citations
  • Comparative analysis of the effect of bevacizumab maintenance regimens after first-line chemotherapy in patients with metastatic colorectal cancer (MCRC): A single institution experience (Song Y, Mohamed A, Ismail H, Abdallah N, Suprapaneni M, Dyson G, Kamgar M, Akhras A, Mettu J, Ahmed A, Tesfaye AA, Philip PA, Shields AF) Journal of Clinical Oncology 35, no. 15_suppl.e15032 05/30/2017    
  • Renal Transplant Outcomes in Waitlist Candidates with a Previous Inactive Status Due to Being Temporarily Too Sick. (Leeaphorn N, Sampaio MS, Natal N, Mehrnia A, Kamgar M, Huang E, Kalantar-Zadeh K, Kaplan B, Bunnapradist S) Clin Transpl 2014:117-24 PMID: 26281135 SCOPUS ID: 2-s2.0-84940992917 01/01/2014       4 Citations
  • Can aminotransferase-to-platelet ratio index and other non-invasive markers effectively reduce liver biopsies for renal transplant evaluation of hepatitis C virus-positive patients? (Jiang Y, Huang E, Mehrnia A, Kamgar M, Pham PT, Ogunorunyinka O, Brown I, Danovitch GM, Bunnapradist S) Nephrol Dial Transplant 2014 Jun;29(6):1247-52 PMID: 24353319 SCOPUS ID: 2-s2.0-84901745221 12/20/2013       9 Citations
  • The impact of pre-transplant dialysis on simultaneous pancreas-kidney versus living donor kidney transplant outcomes. (Wiseman AC, Huang E, Kamgar M, Bunnapradist S) Nephrol Dial Transplant 2013 Apr;28(4):1047-58 PMID: 23355627 SCOPUS ID: 2-s2.0-84876010283 01/29/2013       16 Citations
  • Improved survival among sickle cell kidney transplant recipients in the recent era. (Huang E, Parke C, Mehrnia A, Kamgar M, Pham PT, Danovitch G, Bunnapradist S) Nephrol Dial Transplant 2013 Apr;28(4):1039-46 PMID: 23345624 SCOPUS ID: 2-s2.0-84875982878 01/25/2013       34 Citations
  • Kidney failure requiring kidney transplantation after pancreas transplant alone. (Nata N, Huang E, Kamgar M, Leeaphorn N, Mehrnia A, Kalantar-Zadeh K, Bunnapradist S) Clin Transpl 2013:45-52 PMID: 25095491 SCOPUS ID: 2-s2.0-84906954437 01/01/2013       4 Citations
  • Zero-mismatch deceased-donor kidney versus simultaneous pancreas-kidney transplantation. (Kamgar M, Huang E, Kamgar M, Nata N, Leeaphorn N, Kalantar-Zadeh K, Bunnapradist S) Transplantation 2012 Oct 27;94(8):822-9 PMID: 23032866 SCOPUS ID: 2-s2.0-84868214731 10/04/2012       2 Citations
  • Physical activity in Iran: results of the third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007). (Esteghamati A, Khalilzadeh O, Rashidi A, Kamgar M, Meysamie A, Abbasi M) J Phys Act Health 2011 Jan;8(1):27-35 PMID: 21297182 SCOPUS ID: 2-s2.0-78651361889 02/08/2011       72 Citations
  • Secular trends of obesity in Iran between 1999 and 2007: National Surveys of Risk Factors of Non-communicable Diseases. (Esteghamati A, Khalilzadeh O, Mohammad K, Meysamie A, Rashidi A, Kamgar M, Abbasi M, Asgari F, Haghazali M) Metab Syndr Relat Disord 2010 Jun;8(3):209-13 PMID: 20085488 SCOPUS ID: 2-s2.0-77953746739 01/21/2010       73 Citations
  • Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. (Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, Kamgar M, Gouya MM, Abbasi M) BMC Public Health 2009 May 29;9:167 PMID: 19480675 PMCID: PMC2697989 SCOPUS ID: 2-s2.0-67949099045 06/02/2009       249 Citations
  • Pancreatic Cancer: State of the Art and Current Situation in the Islamic Republic of Iran (Kamgar M, Jamali A, Massarrat S, Sotoudeh M, Larijani B, Adler G, Seufferlein T) Govaresh Govaresh. 2009;14(3):189-197 01/01/2009    
  • Last update: 06/12/2022